钝性腹部实质脏器损伤非手术治疗患者血栓预防时机
该回顾性分析基于2013-2016年TQIP数据库,纳入3,223例孤立性钝性腹部实质脏器损伤(肝、脾、胰腺或肾,其他区域AIS<3)且初始非手术治疗的患者,按血栓预防启动时机分为早期(<48h,1,832例)、中间(48-72h,703例)和晚期(>72h,688例)。与早期相比,晚期启动独立增加DVT(OR 3.15,95%CI 1.68-5.91,p<0.001)和PE(OR 4.29,95%CI 1.95-9.42,p<0.001)风险;中间启动独立增加DVT(OR 2.38,95%CI 1.20-4.74,p=0.013)但不增加PE(p=0.960)。早期启动独立增加出血风险(OR 2.05,95%CI 1.11-2.18,p=0.023),糖尿病史、脾损伤及高级别肝损伤亦与出血相关。结论提示低出血风险者考虑早期预防,特定人群可考虑48-72h延迟。
要点
- 晚期(>72h)启动血栓预防独立增加DVT(OR 3.15,95%CI 1.68-5.91)和PE(OR 4.29,95%CI 1.95-9.42)风险,均p<0.001。
- 中间(48-72h)启动较早期独立增加DVT(OR 2.38,95%CI 1.20-4.74,p=0.013),但不增加PE(p=0.960)。
- 早期(<48h)启动独立增加出血风险(OR 2.05,95%CI 1.11-2.18,p=0.023)。
- 糖尿病史、脾损伤及3-5级肝损伤与出血风险独立相关,可考虑延迟至48-72h启动预防。
- 低出血风险BSOIs非手术治疗患者应考虑早期(<48h)启动血栓预防。
适用人群与场景
- 孤立性钝性腹部实质脏器损伤(肝、脾、胰腺或肾)且其他区域AIS评分<3的患者。
- 初始接受非手术治疗(NOM)的患者。
- 排除:非孤立性BSOIs、其他区域AIS≥3、初始手术治疗者(原文未详细列出其他排除标准)。
诊断标准与关键阈值
- 分组标准:早期<48小时,中间48-72小时,晚期>72小时启动血栓预防。
- 损伤严重度:其他区域AIS评分<3。
- 原文未提及具体的血栓预防药物启动阈值或评分界值。
处置流程与药物剂量
- 第一步:评估出血风险,低出血风险者考虑早期(<48h)启动血栓预防。
- 第二步:对糖尿病史、脾损伤或3-5级肝损伤患者,考虑延迟至48-72h启动血栓预防。
- 原文未提及具体药物名称、剂量、给药途径及频次。
红旗征与不能漏的情况
- 晚期(>72h)启动血栓预防与DVT(OR 3.15)和PE(OR 4.29)风险独立相关。
- 早期(<48h)启动血栓预防与出血风险独立相关(OR 2.05)。
- 糖尿病史、脾损伤及3-5级肝损伤与出血风险独立相关。
研究设计与关键结果
- 研究类型:回顾性分析,基于创伤质量改进计划(TQIP)数据库2013-2016年数据。
- 分组:早期1,832例(56.8%),中间703例(21.8%),晚期688例(21.4%)。
- 主要终点:晚期启动独立增加DVT(OR 3.15,95%CI 1.68-5.91,p<0.001)和PE(OR 4.29,95%CI 1.95-9.42,p<0.001);中间启动独立增加DVT(OR 2.38,95%CI 1.20-4.74,p=0.013)但不增加PE(p=0.960);早期启动独立增加出血(OR 2.05,95%CI 1.11-2.18,p=0.023)。
- 关键次要终点:糖尿病史、脾损伤及高级别肝损伤与出血风险独立相关(原文未提供具体OR值)。
- 不良事件:原文未单独报告其他不良事件。
证据类型、等级与局限
- 证据类型:回顾性队列研究(基于TQIP数据库)。
- 证据等级:Level IV(治疗性研究)。
- 局限:原文未述局限性。
对床旁实践的改变
- 对BSOIs非手术治疗且低出血风险患者,考虑早期(<48h)启动血栓预防以降低DVT和PE风险。
- 对糖尿病史、脾损伤或3-5级肝损伤患者,可考虑延迟至48-72h启动血栓预防,以平衡出血风险。
- 原文未提及具体药物方案,临床决策需结合个体化评估。
指南或共识出处
- Timing of thromboprophylaxis in patients with blunt abdominal solid organ injuries undergoing nonoperative management. J Trauma Acute Care Surg. 2013-2016 TQIP数据库分析。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Decision making regarding the optimal timing for initiating thromboprophylaxis in patients with blunt abdominal solid organ injuries (BSOIs) remains ill-defined, with no guidelines defining optimal timing. In this study, we aimed to evaluate the relationship of the timing of thromboprophylaxis with thromboembolic and bleeding complications in the setting of BSOIs.
METHODS: A retrospective analysis of the Trauma Quality Improvement Program database was performed between 2013 and 2016. All patients with isolated BSOIs (liver, spleen, pancreas, or kidney, Abbreviated Injury Scale score, <3 in other regions) who underwent initial nonoperative management (NOM) were included. Patients were divided into three groups (early, <48 hours; intermediate, 48-72 hours; and late, >72 hours) based on timing of thromboprophylaxis initiation. Primary outcomes were rates of thromboembolism and bleeding after thromboprophylaxis initiation.
RESULTS: Of the 25,118 patients with isolated BSOIs, 3,223 met the inclusion criteria (age, 38.7 ± 17.3 years; males, 2.082 [64.6%]), among which 1,832 (56.8%) received early thromboprophylaxis, 703 (21.8%) received intermediate thromboprophylaxis, and 688 (21.4%) received late thromboprophylaxis. Late thromboprophylaxis initiation was independently associated with a higher likelihood of both deep vein thrombosis (odds ratio [OR], 3.15; 95% confidence interval [CI], 1.68-5.91, p < 0.001) and pulmonary embolism (OR, 4.29; 95% CI, 1.95-9.42; p < 0.001). Intermediate thromboprophylaxis initiation was independently associated with a higher likelihood of deep venous thrombosis (OR, 2.38; 95% CI, 1.20-4.74; p = 0.013), but not pulmonary embolism (p = 0.960) compared with early initiation. Early (but not intermediate) thromboprophylaxis initiation was independently associated with a higher likelihood of bleeding (OR, 2.05; 95% CI, 1.11-2.18; p = 0.023), along with a history of diabetes mellitus, splenic, and high-grade liver injuries.
CONCLUSION: Early thromboprophylaxis should be considered in patients with BSOIs undergoing nonoperative management who are at low likelihood of bleeding. An intermediate delay (48-72 hours) of thromboprophylaxis should be considered for patients with diabetes mellitus, splenic injuries, and Grades 3 to 5 liver injuries.
LEVEL OF EVIDENCE: Therapeutic, Level IV.
参考来源
- Gaitanidis A, Breen KA, Nederpelt C, et al. Timing of thromboprophylaxis in patients with blunt abdominal solid organ injuries undergoing nonoperative management. J Trauma Acute Care Surg. 2021. PMID: 33048907. doi:10.1097/TA.0000000000002972
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。